Pierrefonds

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine	Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease	Active, not recruiting	Phase 1 / Phase 2	2026-08-04	NCT07291635
Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart	Infections, RNA Virus Infections, avian influenza, bird disease, influenza, non-human animal disease, viral infectious disease	Active, not recruiting	Phase 4	2026-01-16	NCT07275060
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults	COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Phase 2 / Phase 3	2022-04-06	NCT04636697

Clinical trials